Standards development for regenerative medicine therapies
Ended Awarded Last action
- Contract number
- 75F40120F80487
- Awardee
-
Nexight Group LLC UEI LBDVN6QLYPY4
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $1,815,203
Award facts
- Opportunity
-
- Notice of Intent to Sole Source - Standards Development for Regenerative Medicine Therapies Special Notice · Posted Jul 7, 2020
- JA - Standards Development for Regenerative Medicine Therapies Limited / Sole Source Justification · Posted Sep 25, 2020
- Contract value 100% obligated
- $1,815,203.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541611 Administrative Management and General Management Consulting Services
- PSC
- B599 Special Studies/Analysis- Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Silver Spring, MD 20910, USA
- Legislative mandates
-
- Clinger-Cohen Act FAR part 39
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $895,203 | |
| Original award | $920,000 |
About this award
Nexight Group LLC, doing business as Nexight, was awarded a $1.8 million firm fixed price delivery order against its Multiple Award Schedule contract by the Department of Health and Human Services' Food and Drug Administration. The two-year contract calls for Nexight to provide standards development services to support the FDA's regenerative medicine therapies programs. Specifically, Nexight will assist the agency in developing standards for evaluating the safety and effectiveness of regenerative medicine products. Drawing from its expertise in regulatory science, Nexight will perform the work at its Silver Spring, Maryland location through September 2022. No subcontractors or set-aside designations were identified for this award in support of the FDA's efforts to facilitate development of advanced therapies.
Quick answers
Who was awarded contract 75F40120F80487?
75F40120F80487 was awarded to Nexight Group LLC by Food and Drug Administration (Department of Health and Human Services) on September 22, 2020.
How much is contract 75F40120F80487 worth?
The government has obligated $1,815,203 on 75F40120F80487.
Is contract 75F40120F80487 an order under another contract?
Yes. 75F40120F80487 is a delivery order under GS10F176AA, a federal supply schedule, on Multiple Award Schedule (MAS).
Was contract 75F40120F80487 competed?
The extent of competition for 75F40120F80487 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award